222 related articles for article (PubMed ID: 15748148)
21. Chronic exposure to mu-opioid agonists produces constitutive activation of mu-opioid receptors in direct proportion to the efficacy of the agonist used for pretreatment.
Liu JG; Prather PL
Mol Pharmacol; 2001 Jul; 60(1):53-62. PubMed ID: 11408600
[TBL] [Abstract][Full Text] [Related]
22. Endogenous RGS protein action modulates mu-opioid signaling through Galphao. Effects on adenylyl cyclase, extracellular signal-regulated kinases, and intracellular calcium pathways.
Clark MJ; Harrison C; Zhong H; Neubig RR; Traynor JR
J Biol Chem; 2003 Mar; 278(11):9418-25. PubMed ID: 12524446
[TBL] [Abstract][Full Text] [Related]
23. A conserved arginine in the distal third intracellular loop of the mu-opioid receptor is required for G protein activation.
Wang HL
J Neurochem; 1999 Mar; 72(3):1307-14. PubMed ID: 10037504
[TBL] [Abstract][Full Text] [Related]
24. Nociceptin (ORL-1) and mu-opioid receptors mediate mitogen-activated protein kinase activation in CHO cells through a Gi-coupled signaling pathway: evidence for distinct mechanisms of agonist-mediated desensitization.
Hawes BE; Fried S; Yao X; Weig B; Graziano MP
J Neurochem; 1998 Sep; 71(3):1024-33. PubMed ID: 9721727
[TBL] [Abstract][Full Text] [Related]
25. Differential modulation of mu-opioid receptor signaling to adenylyl cyclase by regulators of G protein signaling proteins 4 or 8 and 7 in permeabilised C6 cells is Galpha subtype dependent.
Talbot JN; Roman DL; Clark MJ; Roof RA; Tesmer JJ; Neubig RR; Traynor JR
J Neurochem; 2010 Feb; 112(4):1026-34. PubMed ID: 20002516
[TBL] [Abstract][Full Text] [Related]
26. Role of extracellular signal-regulated kinases in opioid-induced adenylyl cyclase superactivation in human embryonic kidney 293 cells.
Tso PH; Wong YH
Neurosci Lett; 2001 Dec; 316(1):13-6. PubMed ID: 11720767
[TBL] [Abstract][Full Text] [Related]
27. Implications of phosphoinositide 3-kinase in the mu- and delta-opioid receptor-mediated supraspinal antinociception in the mouse.
Narita M; Ohnishi O; Nemoto M; Yajima Y; Suzuki T
Neuroscience; 2002; 113(3):647-52. PubMed ID: 12150784
[TBL] [Abstract][Full Text] [Related]
28. Opioid-related (ORL1) receptors are enriched in a subpopulation of sensory neurons and prolonged activation produces no functional loss of surface N-type calcium channels.
Murali SS; Napier IA; Rycroft BK; Christie MJ
J Physiol; 2012 Apr; 590(7):1655-67. PubMed ID: 22371475
[TBL] [Abstract][Full Text] [Related]
29. Heterodimerization and cross-desensitization between the mu-opioid receptor and the chemokine CCR5 receptor.
Chen C; Li J; Bot G; Szabo I; Rogers TJ; Liu-Chen LY
Eur J Pharmacol; 2004 Jan; 483(2-3):175-86. PubMed ID: 14729105
[TBL] [Abstract][Full Text] [Related]
30. Functional coupling, desensitization and internalization of virally expressed mu opioid receptors in cultured dorsal root ganglion neurons from mu opioid receptor knockout mice.
Walwyn WM; Keith DE; Wei W; Tan AM; Xie CW; Evans CJ; Kieffer BL; Maidment NT
Neuroscience; 2004; 123(1):111-21. PubMed ID: 14667446
[TBL] [Abstract][Full Text] [Related]
31. Opioid receptor subtypes differentially modulate serotonin efflux in the rat central nervous system.
Tao R; Auerbach SB
J Pharmacol Exp Ther; 2002 Nov; 303(2):549-56. PubMed ID: 12388635
[TBL] [Abstract][Full Text] [Related]
32. GRK2 protein-mediated transphosphorylation contributes to loss of function of μ-opioid receptors induced by neuropeptide FF (NPFF2) receptors.
Moulédous L; Froment C; Dauvillier S; Burlet-Schiltz O; Zajac JM; Mollereau C
J Biol Chem; 2012 Apr; 287(16):12736-49. PubMed ID: 22375000
[TBL] [Abstract][Full Text] [Related]
33. Opioid receptor-like (ORL1) receptor utilizes both G(oA) and G(oB) for signal transduction.
Tso PH; Wong YH
Protein Pept Lett; 2006; 13(5):437-41. PubMed ID: 16800795
[TBL] [Abstract][Full Text] [Related]
34. Phosphorylation of the mu-opioid receptor at tyrosine 166 (Tyr3.51) in the DRY motif reduces agonist efficacy.
Clayton CC; Bruchas MR; Lee ML; Chavkin C
Mol Pharmacol; 2010 Mar; 77(3):339-47. PubMed ID: 19959593
[TBL] [Abstract][Full Text] [Related]
35. The functional antiopioid action of the ventrolateral periaqueductal gray nociceptin/orphanin FQ and nociceptin receptor system underlies DAMGO analgesic tolerance.
Parenti C; Scoto GM
Pharmacology; 2010; 86(3):138-44. PubMed ID: 20689345
[TBL] [Abstract][Full Text] [Related]
36. Autoradiographic mapping of the opioid receptor-like 1 (ORL1) receptor in the brains of mu-, delta- or kappa-opioid receptor knockout mice.
Slowe SJ; Clarke S; Lena I; Goody RJ; Lattanzi R; Negri L; Simonin F; Matthes HW; Filliol D; Kieffer BL; Kitchen I
Neuroscience; 2001; 106(3):469-80. PubMed ID: 11591451
[TBL] [Abstract][Full Text] [Related]
37. Differential effects of gestational buprenorphine, naloxone, and methadone on mesolimbic mu opioid and ORL1 receptor G protein coupling.
Hou Y; Tan Y; Belcheva MM; Clark AL; Zahm DS; Coscia CJ
Brain Res Dev Brain Res; 2004 Jul; 151(1-2):149-57. PubMed ID: 15246701
[TBL] [Abstract][Full Text] [Related]
38. Influence of a deletion of protein kinase C gamma isoform in the G-protein activation mediated through opioid receptor-like-1 and mu-opioid receptors in the mouse pons/medulla.
Narita M; Mizoguchi H; Khotib J; Suzuki M; Ozaki S; Yajima Y; Narita M; Tseng LF; Suzuki T
Neurosci Lett; 2002 Oct; 331(1):5-8. PubMed ID: 12359310
[TBL] [Abstract][Full Text] [Related]
39. GPCR dimerization in brainstem nuclei contributes to the development of hypertension.
Sun GC; Ho WY; Chen BR; Cheng PW; Cheng WH; Hsu MC; Yeh TC; Hsiao M; Lu PJ; Tseng CJ
Br J Pharmacol; 2015 May; 172(10):2507-18. PubMed ID: 25573074
[TBL] [Abstract][Full Text] [Related]
40. A6V polymorphism of the human μ-opioid receptor decreases signalling of morphine and endogenous opioids in vitro.
Knapman A; Santiago M; Connor M
Br J Pharmacol; 2015 May; 172(9):2258-72. PubMed ID: 25521224
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
